Molecular Diagnostics Market Share (USD 9.86% By 2030): A Growing Industry and Its Impact on Healthcare Systems

Molecular diagnostics is a branch of laboratory medicine that uses molecular biology techniques to diagnose and monitor diseases at the molecular level. Molecular diagnostics techniques involve analyzing DNA, RNA, and other molecules to detect specific genetic or molecular markers associated with a disease. Molecular diagnostics can be used to identify genetic mutations or other molecular changes that may increase a patient's risk of developing certain diseases. It can also be used to diagnose infectious diseases by detecting the genetic material of the pathogen causing the disease.

 Some of the techniques commonly used in molecular diagnostics include polymerase chain reaction (PCR), nucleic acid hybridization, next-generation sequencing (NGS), and microarrays. These techniques can be used to analyze a wide range of samples, including blood, tissue, and body fluids.


Increase in the prevalence of infectious diseases and various types of cancer drives the growth of the molecular diagnostics market. On the other hand, stringent regulatory requirements for the approval of new molecular diagnostics techniques are expected to hinder the growth of the market. However, surge in adoption of the molecular diagnostics in the emerging economies is projected to offer numerous opportunities in the industry.

Key players in the industry

  • Abbott Laboratories
  • Becton
  • F. Hoffmann-La Roche AG
  • Qiagen N.V.
  • Hologic Corporation
  • Grifols
  • Danaher Corporation, S.A.
  • Agilent Inc.
  • Dickinson and Company
  • BioMรฉrieux SA
  • Siemens Healthcare GmbH

Based on product type, the reagents segment accounted for more than half of the global molecular diagnostics market share in 2020, and is anticipated to rule the roost by 2030. The same segment would also cite the fastest CAGR of 10.16% throughout the forecast period. Advancements in R&D activities in the pharmaceutical & biotechnology industry, increase in demand for reagents and surge in adoption of point-of-care testing drive the segment growth.

Based on application, the infectious diseases segment held nearly half of the global molecular diagnostics market revenue in 2020 and is expected to lead the trail by 2030, due to the growing incidence of infectious diseases such as SARS-COV-19. The genetic testing segment, on the other hand, would manifest the fastest CAGR of 10.31% from 2021 to 2030. This is attributed to the increase in the prevalence of genetic diseases among individuals across the world.

Based on region, North America, held the major share in 2020, generating more than two-fifths of the global molecular diagnostics market, due to the presence of large number of key players across the region. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 10.78% by 2030, owing to higher adoption & increased use of molecular diagnostics, a rapidly growing geriatric population, and rise in the incidence of infectious diseases across the province.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2170

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?

• Which are the roadblock factors of this market?

• What are the new opportunities, by which market will grow in coming years?

• What are the trends of this market?

• Which are main factors responsible for new product launch?

• How big is the global & regional market in terms of revenue, sales and production?

• How far will the market grow in forecast period in terms of revenue, sales and production?

• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?

• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?

• Which region has more opportunities?

By Region Outlook

• North America

(U.S., Canada, Mexico)

• Europe

(Germany, France, UK, Italy, Spain, Rest of Europe)

• Asia-Pacific

(Japan, China, India, Rest of Asia-Pacific)

• LAMEA

(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa

USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022

help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy in Singapore: Advancements, Opportunities, and Challenges

Image
Gene therapy is an experimental medical technique that uses genetic material to treat or prevent diseases. The technique involves introducing genes into a patient's cells to replace or repair abnormal genes that are responsible for causing a disease. Gene therapy has the potential to treat a wide range of diseases, including inherited disorders, cancer, and viral infections. In this blog, we will discuss the basics of gene therapy, its types, benefits, and limitations. Singapore is actively involved in gene therapy research and development, and the country has made significant strides in the field. With the government's support and ongoing research initiatives, Singapore is well-positioned to become a leading hub for gene therapy research and development in the Asia-Pacific region. Allied Market Research has published a study report with the title Gene Therapy Market Size was Valued at USD 6.0 billion in 2020 and is Projected to Garner USD 46.5 billion by 2030 , registering a...
Read more

Smart Hospitals Market Size Worth USD 58.77 Billion by 2025

Image
  A smart hospital is a healthcare facility that uses technology to optimize patient care and hospital operations. This includes the use of electronic medical records, telemedicine, medical devices connected to the internet, and other digital tools. The goal of a smart hospital is to improve patient outcomes, reduce costs, increase efficiency, and enhance the overall patient experience. Smart hospitals also incorporate design elements to create a more patient-centered environment. This may include private rooms with comfortable furnishings, natural light, and access to entertainment and information. Overall, a smart hospital aims to create a modern, efficient, and patient-focused healthcare environment. Allied Market Research has published a study report with the title  Smart Hospitals Market Size  is Anticipated to Garner USD 58,777 million by 2025, growing at a CAGR of 17.3% During Forecast Period. The report provides a detailed analysis of the top investment pockets, ...
Read more

Exploring Singapore's Healthcare Landscape: A Market Analysis of Medical Tourism

Image
Medical tourism is the practice of traveling to another country to receive medical treatment or procedures. People may choose to travel for medical care for a variety of reasons, including cost savings, access to specialized treatments or facilities, shorter wait times, and the opportunity to combine medical care with a vacation or travel experience. Medical tourism typically involves traveling to a country where the cost of medical care is lower than in one's home country. This can be particularly appealing for people who are uninsured, underinsured or facing high out-of-pocket costs for medical treatment. Some common types of medical treatments and procedures that people travel for include dental care, cosmetic surgery, fertility treatments, and major surgeries such as heart surgery or joint replacement. Allied Market Research has just completed and published a study report with the title Medical Tourism Market Size is Projected to Garner USD 273.72 billion by 2027 registerin...
Read more